Codexis Presents Pre-Clinical Data Highlighting Gene Therapy Programs at the ASGCT 25th Annual Meeting
At Codexis, we strive to discover and develop more effective therapeutics, offer healthier choices, innovate sustainable processes and products, and reduce waste – all to create a brighter future.
These goals are grand but not beyond reach. Together with our business partners and loyal customers, we can make them a reality.
A paper authored by Merck and Codexis in the June 2022 issue of the peer-reviewed journal Science, details the development of a suite of enzymes and their application for site-selective synthesis of insulin bioconjugates.View Paper